As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major ...

The European Medicines Agency is investigating Novo Nordisk’s diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland’s health regulator flagged three cases of patients thinking about ...

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has urged healthcare professionals to ensure patients and the public are aware of the dangers of falsified Ozempic (semaglutide) and ...

The review comes after three people reported thoughts of self-harm or suicide. Regulators in Europe have launched a review after three people in Iceland experienced thoughts of suicide or self-harm ...